Evidence map›Paper›PMID 39106522›Full record

ArticleAnnals of the American Thoracic Society2024

A Retrospective Evaluation of the Treatment Effects of Rituximab in Patients with Progressive and Symptomatic Fibrosing Mediastinitis.

Cyril Varghese, Geoffrey B Johnson, Patrick W Eiken, Eric S Edell, Ulrich Specks, Nicholas B Larson, Tobias Peikert

Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of the American Thoracic Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06980584 (Analysis of Clinical Characteristics and Follow-Up Study on Treatment of Nonthrombotic Obstructive Pulmonary Hypertension), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06980584 narecruitingnot on this mapstarted 2025, after this paper: background citation

Analysis of Clinical Characteristics and Follow-Up Study on Treatment of Nonthrombotic Obstructive Pulmonary Hypertension: Interventional Study

TypeinterventionalSponsorBeijing Chao Yang HospitalRan2025 to 2027Enrolled48ConditionsFibrosing Mediastinitis, Pulmonary HypertensionArmsRituximab Lymph Node Injection Combined with Pulmonary Vascular Intervention, Pulmonary Vascular Interventional Therapy
3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Diagnostic and management dilemmas in pulmonary hypertension.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Cyril VargheseDivision of Pulmonary and Department of Critical Care Medicine, Mayo Clinic, Phoenix, Arizona; and.
Geoffrey B JohnsonDepartment of Radiology.
Patrick W EikenDepartment of Radiology.
Eric S EdellDivision of Pulmonary Medicine, and.
Ulrich SpecksDivision of Pulmonary Medicine, and.
Nicholas B LarsonDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.
Tobias PeikertDepartment of Immunology.

Funding

Institutional Career Development CoreKL2TR002379 · NCATS · MAYO CLINIC ROCHESTER · PI NILUFER ERTEKIN-TANER · 2017 to 2026
$14.9M
NCATS NIH HHS KL2 TR002379
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MediastinitisRituximabAdolescentAdultAgedDisease ProgressionFemaleHumansImmunologic FactorsMaleMiddle AgedOff-Label UseRetrospective StudiesSclerosisTomography, X-Ray ComputedTreatment OutcomeImmunologic FactorsRituximabfibrosing mediastinitishistoplasmosismedical therapyrituximab

Identifiers

PMID39106522
PMCPMC12392372

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.